SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-222579
Filing Date
2020-08-18
Accepted
2020-08-17 18:54:04
Documents
15
Period of Report
2020-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60848d8k.htm   iXBRL 8-K 44364
2 EX-4.2 d60848dex42.htm EX-4.2 143561
3 EX-4.3 d60848dex43.htm EX-4.3 92295
  Complete submission text file 0001193125-20-222579.txt   505911

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amgn-20200817.xsd EX-101.SCH 4547
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20200817_def.xml EX-101.DEF 13773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20200817_lab.xml EX-101.LAB 22821
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20200817_pre.xml EX-101.PRE 14742
8 EXTRACTED XBRL INSTANCE DOCUMENT d60848d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 201111135
SIC: 2836 Biological Products, (No Diagnostic Substances)